The Right Way To Do Paid Cannabis Ads (And The Wrong Ways)

Paid advertising is hard. Not cannabis-hard — just hard. The vast majority of businesses that run paid campaigns on Google or Meta do it wrong, spend more than they make, and either give up or keep throwing money at campaigns that will never perform. The analytics are complex, the optimization takes time and expertise, and the gap between a campaign that generates revenue and one that burns budget is almost entirely in the execution. Of course, most industries get to learn these lessons on open platforms with abundant data and clear rules. Unfortunately, cannabis doesn't have this luxury.

The Hood Collective works with cannabis businesses on marketing strategy, and paid advertising is where we see some of the most consistent and most expensive mistakes. Not just because the platforms are restricted — though they are — but because operators come in assuming the hard part is getting the ads approved, when the hard part is actually everything that comes after. Access to the platforms is a solved problem if you know what you're doing. Building campaigns that generate a return is where most operators, in cannabis and outside of it, fall short.

Cannabis Advertising in 2026: CBD and THC Are Not the Same

The first mistake most cannabis operators make before spending a dollar on paid advertising is treating CBD and THC as the same category. They aren't — not from a regulatory standpoint, not from a platform standpoint, and not from a strategy standpoint. How you approach paid advertising depends heavily on which one you're selling, and conflating the two leads to wasted budget and avoidable account suspensions.

CBD, particularly hemp-derived CBD with less than 0.3% THC, has meaningfully more advertising access than THC. Major platforms have gradually opened doors for CBD brands that meet certification requirements — primarily LegitScript, a third-party merchant monitoring service that Google, Meta, and others use to verify compliant advertisers. Getting LegitScript certified requires proof that your products are hemp-derived, third-party lab testing for every product category, and a website that meets specific compliance standards. It's not a simple process, but it's a defined one. On Google, LegitScript-certified CBD topicals can run paid ads in California, Colorado, and Puerto Rico. On Meta, certified non-ingestible CBD products — topicals, skincare, anything that isn't ingested — can run with 21+ targeting. Ingestible CBD products, including edibles, tinctures, and capsules, remain off limits on both platforms regardless of certification.

THC operates in a different lane entirely. Officially, Google and Meta prohibit THC advertising outright — no exceptions, no certification pathway, no workaround through the front door. In practice, THC ads run on both platforms regularly, which is a reality the next section addresses in detail. What matters here is understanding that THC operators cannot follow the CBD playbook. LegitScript certification won't help, and attempting to run straightforward THC product ads the way a CBD brand might will get an account suspended faster than almost anything else a cannabis marketer can do.

The distinction also matters beyond Google and Meta. On endemic platforms like Weedmaps and Leafly, both CBD and THC brands can advertise directly to high-intent cannabis consumers with relatively few restrictions. On programmatic networks and Connected TV, both categories have access through cannabis-friendly demand-side platforms that handle compliance at the network level. But the strategy, the creative, the landing pages, and the compliance requirements differ between the two — and operators who don't account for that difference from the start are building on a shaky foundation.

Can You Run Cannabis Ads on Google and Meta? Yes, With the Right Approach

One of the most common questions cannabis operators ask is why their competitors seem to be running ads on Google and Meta when they've been told it isn't allowed. The answer isn't that their competitors found a compliant pathway that nobody told them about. It's that a lot of operators run non-compliant ads until the platform catches up with them — and eventually it does. Accounts get suspended, campaigns get pulled, and the operator starts over with a new account and does it again. This creates a persistent illusion in the market that cannabis ads on Google and Meta are simply a matter of doing it, when the reality is that most of those ads are running on borrowed time. Seeing a competitor run cannabis ads doesn't mean those ads are compliant, sustainable, or profitable. It means they haven't been caught yet — and when they are, they lose the account, potentially permanently, without recovering any of the budget spent building it.

The compliant approach is different in one fundamental way: neither the ad copy nor the landing page ever explicitly mentions cannabis. The landing page exists to satisfy the platform's review process and links through to the brand's actual website, where the full picture lives. Nothing in the ad or the landing page triggers the platform's automated review systems. This isn't a workaround so much as it is a disciplined understanding of where the line is. It requires careful campaign architecture, compliant creative, and landing pages built specifically for this purpose — and it requires ongoing management, because platforms update their review systems constantly and what passes today may not pass next month. CBD brands with LegitScript certification have a more defined path on both platforms. THC operators have a narrower one, but operators who know how to build and manage these campaigns are running them.

Meta is harder than Google. Its review systems are more aggressive, its tolerance for gray area is lower, and campaigns require more active management to keep running. The cost of running compliant campaigns on Meta is higher in both time and spend, which is part of why it tends to make sense only for operators with sufficient budget and a specific use case that justifies it.

For operators who want to avoid the platform policy question entirely, endemic platforms like Weedmaps and Leafly offer a straightforward alternative. Both are open to CBD and THC without workarounds, and they reach an audience that is already in a cannabis purchasing mindset — which makes the conversion path shorter and the audience quality higher than a cold audience on Google or Meta. Programmatic display and Connected TV open up broader reach through cannabis-friendly networks that handle compliance at the network level. Age-gating and geo-fencing are built in, campaigns can run at scale, and operators don't have to navigate platform policy on their own.

Running compliant cannabis ads on Google or Meta is expensive and complicated even before you get to the question of whether they're working. The platform work — campaign architecture, compliant creative, landing pages, ongoing management as review systems update — requires real expertise and real budget. Most operators who invest in cannabis paid advertising underestimate both, and end up spending money on campaigns they can't evaluate because they don't have the analytics foundation to know what the data is telling them. Getting the ads running is one problem. Knowing whether they're worth running is another one entirely.

When Paid Cannabis Advertising Makes Sense — And When It Doesn't

Paid advertising works best when the distance between seeing an ad and making a purchase is as short as possible. A customer who clicks an ad, lands on an ordering page, and completes a purchase in the next few minutes is the ideal scenario. Every step added between the ad and the transaction is an opportunity to lose the customer — and in cannabis, where paid advertising is already more expensive and more complicated than in most industries, a long conversion path doesn't just make attribution harder. It makes the economics nearly impossible to defend.

The use cases where paid cannabis advertising makes the most sense are the ones where that conversion path is shortest. Delivery is the clearest example. A customer sees an ad, clicks through to an ordering page, selects their products, and has them brought to their door. There is no driving, no stopping at a competitor along the way, no browsing in a store before deciding to leave. The transaction happens as a direct result of the ad, and that direct line between spend and revenue is what makes optimization possible. Online ordering for in-store pickup works the same way — the customer commits to the purchase before they ever leave home, which means the dispensary visit is already a done deal by the time they get in the car. CBD retail is another strong use case, with the added advantage of fewer platform restrictions and a more straightforward path to running compliant campaigns at scale.

The use cases where paid cannabis advertising struggles are the ones with the longest conversion paths. Driving foot traffic is the hardest case to make. A customer sees an ad, decides they might want to visit, gets in the car, drives past a competitor, walks into whichever dispensary they end up at, browses, and maybe makes a purchase. At no point in that chain is the original ad clearly responsible for the outcome, and the cost of buying enough impressions to move the needle on foot traffic at a single location is significant. Brand awareness campaigns have a similar problem — the conversion path between an awareness impression and a purchase is long, indirect, and nearly impossible to measure with any confidence. In an industry where every dollar of ad spend costs more than it would elsewhere, spending on outcomes you can't track is a difficult position to defend.

The question every cannabis operator should ask before committing to paid advertising is how many steps stand between a customer seeing their ad and completing a purchase. The fewer the better — and the answer to that question should determine whether paid advertising makes sense for the business at all.

Why You Need A Significant Cannabis Ad Budget

Most cannabis operators who try paid advertising and conclude it doesn't work didn't give it a fair test. They ran a small budget campaign, saw underwhelming results, and stopped. What they didn't realize is that an underfunded cannabis ad campaign doesn't just underperform — it actively misleads. The data it produces isn't reliable enough to draw conclusions from, which means every optimization decision made on the back of it is built on a foundation that isn't solid.

Budget in paid advertising isn't just about reach — it's about generating enough data to learn from. Optimization is an iterative process: you run campaigns, collect data on what's working and what isn't, make adjustments, and run again. That process requires enough volume to be statistically meaningful. A campaign generating a handful of clicks and conversions per week doesn't produce enough signal to tell you anything with confidence. You can't determine whether an ad is underperforming because the creative is wrong, the audience is wrong, the landing page is wrong, or the offer is wrong — because the sample size isn't large enough to tell you. Below a certain spending level, platforms also treat campaigns as a lower priority, delivering to a less valuable audience at a worse time for a higher effective cost than a properly funded campaign would.

In practice, campaigns running below $1,000 a month rarely generate enough data or enough platform priority to be worth the investment. That's not a magic number — operators in competitive markets or running campaigns across multiple platforms will need significantly more. But it's a practical floor, and the honest advice for any cannabis operator who can't commit to at least that level consistently is to not run paid ads at all. A small budget doesn't buy you a smaller version of what a real campaign delivers. It buys you noise — data that feels actionable but isn't, results that feel meaningful but aren't, and a conclusion that paid advertising doesn't work when the real conclusion is that underfunded advertising doesn't work. Save the budget for when you can do it properly, or spend it somewhere it can actually move the needle.

How to Track ROI on Cannabis Paid Advertising

Every paid advertising campaign lives or dies on the quality of its analytics setup, and that setup requires enough data to be meaningful — which is inseparable from why budget matters as much as it does. Before a single dollar is spent on ads, the technical foundation needs to be in place — conversion tracking configured correctly, analytics properly connected to the campaign, and attribution set up in a way that actually tells you where revenue is coming from. This isn't cannabis-specific. It's the baseline requirement for running any paid campaign that you intend to evaluate honestly, and it's where a surprising number of operators across every industry fall short before they even get started.

In cannabis, getting that foundation right is harder than in most categories. Platform restrictions affect what tracking tools can be installed, what data can be collected, and how conversion events can be reported back to the ad platform. A dispensary running compliant campaigns through a landing page that redirects to their main site has a more complex attribution chain than a standard e-commerce business — and gaps in that chain mean gaps in the data. Delivery and online ordering operations have cleaner attribution because the conversion happens digitally, but they still require careful setup to ensure the data flowing back to the campaign is complete and accurate enough to optimize from.

What good ROI tracking looks like in practice is a clear, unbroken line between ad spend and revenue. Which campaigns are driving orders. Which audiences are converting at what cost. Which creative is performing and which isn't. How lifetime customer value compares to cost per acquisition. Getting to those answers requires not just the right analytics setup but a disciplined approach to A/B testing — running controlled variations of ad creative, audience targeting, landing pages, and offers to understand what's actually driving performance and what isn't. Without testing, optimization is opinion. With it, every dollar spent is generating data that makes the next dollar more effective.

The expertise required to build that foundation, maintain it as platforms update their systems, interpret the data correctly, and translate it into better campaign decisions over time is significant. It's also where most operators fall short — not because the concepts are beyond them, but because building and running effective paid campaigns while managing a cannabis business is a full time job on top of a full time job. The operators who get the best return from paid advertising are almost never the ones running it themselves.

Cannabis Paid Advertising Done Right: The Hood Collective

Paid cannabis advertising works — for the right business model, with the right budget, and the right expertise behind it. Getting there requires understanding the platform landscape, building campaigns designed to last, and having the analytics foundation to know what's working and why. Most operators who try it without those three things spend money they can't get back learning lessons they could have avoided.

At The Hood Collective, we handle the campaign architecture, compliance, analytics setup, A/B testing, and ongoing optimization that turns ad spend into a return worth measuring. If you want to know whether paid advertising makes sense for your business, schedule a free consultation today.